Dixon Technologies Vivo JV: Rs 30,000 Cr Focus 2026

What the latest update signals

Dixon Technologies Ltd. is inching closer to a revenue opportunity of around INR 30,000 crore as the government is likely to approve its proposed joint venture with global smartphone brand Vivo, NDTV Profit reported, citing sources. The update follows a Saturday meeting where an inter-ministerial committee is understood to have backed the proposal. The recommendation is expected to move through the prescribed regulatory process before final clearance is granted. The approval process has taken longer than initially expected, with sources pointing to heightened regulatory scrutiny around Vivo India.

For Dixon, the proposed partnership is positioned as a scale-up move in smartphone manufacturing, and it aligns with India’s broader policy push for domestic ownership and control in the electronics supply chain. The structure being discussed includes Dixon acquiring a controlling stake in Vivo’s local manufacturing operations.

Inter-ministerial panel backing and the next steps

According to the information cited by NDTV Profit, the inter-ministerial committee includes officials from NITI Aayog, the Ministry of Home Affairs (MHA), and other stakeholders. Sources indicated that the committee backed the proposal in the Saturday meeting. The file is expected to proceed through regulatory steps, which were described as procedural once the recommendation is in place.

Even so, the JV still needs clearances. The “Market snapshot” shared in the material points to pending approvals from the Ministry of Electronics and Information Technology (MeitY) and the MHA. Separately, Dixon has also referred to the need for PN3 approval for joint ventures involving investments linked to neighbouring countries, including China.

Proposed structure: controlling stake and manufacturing transfer

Dixon is in negotiations to acquire a majority stake, typically cited as 50% to 51%, in Vivo Mobile India’s manufacturing arm. The stated intent is to secure domestic control while continuing manufacturing operations in India.

Dixon’s management commentary also points to significant volume transfer into the JV. The company’s understanding, as stated in the supplied text, is that around 67% of Vivo’s volume should be transferred to the joint venture. In the same set of remarks, Dixon referenced an annualised volume of “closer to 22 odd million” units, along with a better selling price compared with Dixon’s existing portfolio.

What Dixon has said publicly about the timing

In the company’s earnings interaction last month, management indicated that approval was expected soon, but did not provide a fresh timeline later, stating that the proposal remained under active consideration by the government. The Vivo venture has been awaiting approval for several months.

Speaking to NDTV Profit, Saurabh Gupta, Executive Director and Group CFO of Dixon Technologies, said the company remains engaged with the government and does not see structural roadblocks. He added that related matters have been “well settled and agreed upon” and that his sense is approval “should come in soon.”

On the Q4 earnings call, Dixon Managing Director and CEO Atul Lall also said the company was deeply engaged with the government and that it felt “very, very close” to the approval, while acknowledging delays and “aberrations” around the clearance process.

Delays and the role of regulatory scrutiny

Multiple parts of the provided material link delays to scrutiny around Vivo India. One key overhang cited is an ongoing Enforcement Directorate (ED) probe into Vivo under the Prevention of Money Laundering Act (PMLA). The text also states that the probe alleges Vivo illegally transferred INR 62,476 crore to China to evade taxes, and that the investigation involved arrests of company executives.

Media reporting cited in the material suggests the MHA is expected to take a final call on the proposal, and that continued scrutiny could weigh on the approval process. Separately, the updates also indicate the proposal remains under active review and that the ED probe creates uncertainty around the timeline.

Manufacturing ramp-up: units and implementation time

Dixon has shared operational expectations tied to the approval. During the earnings interaction last month, management indicated the JV could add 12-15 million units of manufacturing volume in the first year of operations.

Management commentary in the supplied text also lays out execution timelines after clearance. Dixon indicated it could take about 45 days to consummate the transaction once approval comes through, and another update suggests it could take 45-60 days to ramp up the venture after approvals.

Stock movement after the report

A market reference in the material notes that Dixon’s intraday chart showed a spike after the information came to light, with the stock trading at gains of about 0.8% at the time mentioned. The move reflects how closely investors are tracking approval-related developments, given the potential impact on volumes and scale.

Revenue and growth expectations tied to the JV

The report frames the Vivo partnership as a potential driver of Dixon’s next leg of growth. One update in the material says Dixon expects revenue growth of 15-17% in FY27, with management expecting growth to accelerate to as much as 45% if its long-pending joint venture with Vivo gets government approval.

Separately, the same set of inputs links the JV to a revenue opportunity of about INR 30,000 crore. While the timing of revenue conversion will depend on approvals and ramp-up, the explicit linkage in the report explains why the market is focused on regulatory outcomes.

Key facts at a glance

Timeline and milestones referenced

Why this matters for India’s electronics supply chain

The proposed structure, with Dixon taking a controlling interest in local manufacturing operations, is positioned as consistent with India’s push for domestic ownership in electronics manufacturing. The focus on a majority stake and regulatory vetting reflects the sensitivity around partnerships that involve Chinese-linked entities.

At the same time, the multiple approval layers referenced, including MeitY, MHA, and PN3 clearance, show that the process is not purely commercial. The mention of the ED investigation in the same context underscores why timelines have been hard to pin down, even as Dixon continues to state that engagement with the government is ongoing.

Conclusion

Dixon’s proposed Vivo joint venture remains in the approval pipeline, but sources cited by NDTV Profit indicate the inter-ministerial committee has backed the proposal and it is moving through regulatory processes. The deal structure under discussion includes Dixon taking a 50-51% stake and potentially absorbing significant smartphone volumes, with management outlining 12-15 million units in the first year and an annualised volume of around 22 million units. The next concrete trigger is final regulatory clearance, with the MHA and MeitY cited as key decision points and PN3 approval also referenced in the context of such partnerships.